RT

Roopali Trivedi

Active Director Director DIN 09794000
DIN 09794000 First appointment Nov 2023 Primary industry Education
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Roopali Trivedi

Data last updated:

Roopali Trivedi is a Director at Bryopetris Pharmaceuticals Private Limited (since 2023). The company operates in Education. Bryopetris Pharmaceuticals Private Limited reported revenue of ₹9.9 Lakh (FY 2025).

DIN 09794000
Primary Designation Director
Industry Education
First Appointment 27 Nov 2023
Oldest Company Age 6 yrs
Largest company Bryopetris Pharmaceuticals Private Limited · ₹9.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Nov 20232020₹9.9 Lakh (FY 2025)Active

Board colleagues of Roopali Trivedi

NameDINCompanyDesignation
Alok Trivedi08859984Bryopetris Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bryopetris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Roopali Trivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roopali Trivedi

Roopali Trivedi currently holds 1 directorship: Bryopetris Pharmaceuticals Private Limited (Director, since 27 Nov 2023, revenue ₹9.9 Lakh (FY 2025)).

Roopali Trivedi was first appointed on 27 Nov 2023 as Director at Bryopetris Pharmaceuticals Private Limited.

The current boards of Roopali Trivedi's companies include Alok Trivedi (Bryopetris Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available